News

Monoclonal antibodies against SARS-CoV-2 were considered a promising approach for the prevention and therapy of coronavirus ...
In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a ...
A+ or A-, B+ or B-, AB+ or AB-, and O+ or O-. The first step is called “forward typing.” Your blood cells are mixed with antibodies against type A and B blood, and the sample is checked to see ...
At present there are approximately 200 antibodies in clinical trials, and the US Food and Drug Administration has approved several antibodies against cancer, transplant rejection, rheumatoid ...
In a new investigation, scientists from La Jolla Institute for Immunology (LJI) have shown how antibodies, collected from this clinical study volunteer, bind to the SARS-CoV-2 "Spike" protein to ...
AUSTIN, Texas, March 13, 2025--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) is pleased to announce a strategic partnership with a leading biotechnology company with a multi ...
Many people who have been infected with SARS-CoV-2 will probably make antibodies against the virus for most of their lives. So suggest researchers who have identified long-lived antibody-producing ...
Many babies have maternal mRNA-vaccine antibodies at 6 months Sign up here. At six months of age, babies born to mothers vaccinated against COVID-19 during pregnancy are more likely to have ...
More than three years into the pandemic, an overwhelming majority of Americans have some level of COVID-19 antibodies circulating in their bodies, the U.S. Centers for Disease Control and ...
In the CDC’s new study, researchers used data on antibodies—proteins the body generates to fight off an infection—to better understand how many people in the U.S. previously had COVID-19.
Vaccines do not wipe out the natural antibodies of people who have previously been infected with COVID-19, as has been claimed online. A TikTok video has been shared on Twitter and Facebook with ...